10x Genomics, Inc. develops life science technology for analyzing biological systems at the single-cell and spatial levels. Its platforms are designed to help researchers study gene expression, genetic variation, cell populations and tissue organization with greater detail than conventional laboratory methods.
The company’s product portfolio includes the Chromium platform for single-cell analysis, Visium solutions for spatial transcriptomics and tissue profiling, and Xenium in situ platforms for high-resolution analysis of RNA and other biological features within tissue samples. These products generally combine specialized instruments, consumables, reagents and software for use in applications such as oncology, immunology, neuroscience, developmental biology and drug discovery.
Founded in 2012 and headquartered in Pleasanton, California, 10x Genomics serves academic, government, pharmaceutical and biotechnology research organizations worldwide. The company was co-founded by Serge Saxonov, who serves as its chief executive officer, and its technologies are used by researchers seeking to understand complex biological processes and develop new approaches to disease research and precision medicine.
AI Generated. May Contain Errors.
